Literature DB >> 16380503

Comprehensive profiling of 8p11-12 amplification in breast cancer.

Véronique Gelsi-Boyer1, Béatrice Orsetti, Nathalie Cervera, Pascal Finetti, Fabrice Sircoulomb, Carole Rougé, Laurence Lasorsa, Anne Letessier, Christophe Ginestier, Florence Monville, Séverine Esteyriès, José Adélaïde, Benjamin Esterni, Catherine Henry, Stephen P Ethier, Frédéric Bibeau, Marie-Joëlle Mozziconacci, Emmanuelle Charafe-Jauffret, Jocelyne Jacquemier, François Bertucci, Daniel Birnbaum, Charles Theillet, Max Chaffanet.   

Abstract

In human carcinomas, especially breast cancer, chromosome arm 8p is frequently involved in complex chromosomal rearrangements that combine amplification at 8p11-12, break in the 8p12-21 region, and loss of 8p21-ter. Several studies have identified putative oncogenes in the 8p11-12 amplicon. However, discrepancies and the lack of knowledge on the structure of this amplification lead us to think that the actual identity of the oncogenes is not definitively established. We present here a comprehensive study combining genomic, expression, and chromosome break analyses of the 8p11-12 region in breast cell lines and primary breast tumors. We show the existence of four amplicons at 8p11-12 using array comparative genomic hybridization. Gene expression analysis of 123 samples using DNA microarrays identified 14 genes significantly overexpressed in relation to amplification. Using fluorescence in situ hybridization analysis on tissue microarrays, we show the existence of a cluster of breakpoints spanning a region just telomeric to and associated with the amplification. Finally, we show that 8p11-12 amplification has a pejorative effect on survival in breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16380503     DOI: 10.1158/1541-7786.MCR-05-0128

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  84 in total

Review 1.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

2.  Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.

Authors:  Zeng-Quan Yang; Gang Liu; Aliccia Bollig-Fischer; Ramsi Haddad; Adi L Tarca; Stephen P Ethier
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

3.  A new treasure in the breast cancer gene hunt.

Authors:  Paul Spellman; Joe Gray
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

4.  Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).

Authors:  Jin Qi; Lei Huo; Yiwei Tony Zhu; Yi-Jun Zhu
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

5.  The FGF/FGFR axis as a therapeutic target in breast cancer.

Authors:  Nicholas Brady; Polly Chuntova; Lindsey K Bade; Kathryn L Schwertfeger
Journal:  Expert Rev Endocrinol Metab       Date:  2013-07

6.  Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.

Authors:  Andrzej B Popławski; Michał Jankowski; Stephen W Erickson; Teresita Díaz de Ståhl; E Christopher Partridge; Chiquito Crasto; Jingyu Guo; John Gibson; Uwe Menzel; Carl Eg Bruder; Aneta Kaczmarczyk; Magdalena Benetkiewicz; Robin Andersson; Johanna Sandgren; Barbara Zegarska; Dariusz Bała; Ewa Srutek; David B Allison; Arkadiusz Piotrowski; Wojciech Zegarski; Jan P Dumanski
Journal:  Eur J Hum Genet       Date:  2010-01-06       Impact factor: 4.246

7.  Relationships linking amplification level to gene over-expression in gliomas.

Authors:  Nicolas Vogt; Anne Gibaud; Anna Almeida; Isabelle Ourliac-Garnier; Michelle Debatisse; Bernard Malfoy
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

8.  RCP is a human breast cancer-promoting gene with Ras-activating function.

Authors:  Jinqiu Zhang; Xuejing Liu; Arpita Datta; Kunde Govindarajan; Wai Leong Tam; Jianyong Han; Joshy George; Christopher Wong; Kalpana Ramnarayanan; Tze Yoong Phua; Wan Yee Leong; Yang Sun Chan; Nallasivam Palanisamy; Edison Tak-Bun Liu; Krishna Murthy Karuturi; Bing Lim; Lance David Miller
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

9.  Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.

Authors:  Tarrik M Zaid; Tsz-Lun Yeung; Melissa S Thompson; Cecilia S Leung; Tom Harding; Ngai-Na Co; Rosie S Schmandt; Suet-Ying Kwan; Cristian Rodriguez-Aguay; Gabriel Lopez-Berestein; Anil K Sood; Kwong-Kwok Wong; Michael J Birrer; Samuel C Mok
Journal:  Clin Cancer Res       Date:  2013-01-23       Impact factor: 12.531

10.  Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.

Authors:  S S Kwek; R Roy; H Zhou; J Climent; J A Martinez-Climent; J Fridlyand; D G Albertson
Journal:  Oncogene       Date:  2009-03-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.